12.11.2024 09:04:57
|
Alzchem Group new partner of FC Bayern Basketball
Alzchem Group new partner of FC Bayern Basketball Munich, November 12, 2024 – FC Bayern Basketball and Alzchem, a company based in Trostberg, have joined forces for the new season to achieve success together. With Alzchem's premium brand Creapure®, the internationally renowned manufacturer of creatine monohydrate will accompany the German champions on their way through the coming season as an official Gold partner. Creapure® stands for the highest purity and quality in the field of sports nutrition and is recognized by athletes worldwide. As the leading and only Western manufacturer of creatine, Alzchem places particular emphasis on “made in Germany” production and innovative technologies. The partnership with FC Bayern Basketball marks a further milestone in the combination of top athletic performance and high-quality nutrition. “We are pleased to have Creapure® at our side as a partner,” says Adrian Sarmiento, Chief Strategy Officer of FCBB. ”With a reliable partner like Creapure®, we are committed to the highest quality and support the team's performance.” The collaboration includes not only direct support for the two-time champions during the season in the EuroLeague and BBL, but also joint marketing and communication measures to emphasize the importance of sports nutrition and performance enhancement. Creapure® will be visible in the communication in the BMW Park, in the new SAP Garden and on the social media channels of FCBB, offering fans important insights into the world of sports nutrition. “FC Bayern Basketball stands for success, commitment and team spirit – values that Creapure® also embodies,” explains Andreas Niedermaier, CEO of the Alzchem Group. ”We are proud to support the team with creatine of the highest quality and look forward to a successful season.” About Creapure® About FC Bayern Basketball About Alzchem The company sees interesting growth prospects for itself in the areas of human and animal nutrition and agriculture in particular. As a result of population growth, it is necessary to achieve efficient food production. Pharmaceutical raw materials and creatine products can contribute to a healthy old age as life expectancy increases. Alzchem is facing up to the goal of sustainability arising from climate change in the field of renewable energies and across the entire company. The fields of fine chemicals and metallurgy offer just as great a perspective. Alzchem Group AG’s broad product range includes dietary supplements, precursors for PCR tests and pharmaceutical raw materials. These offerings are the company’s response to global trends and developments. Alzchem is ideally positioned in this respect and considers itself well prepared for an environmental future and global developments. The company employs around 1,690 people at four production sites in Germany and a plant in Sweden, as well as three sales companies in the USA, China and England. Alzchem generated Group sales of EUR 540.6 million and EBITDA of EUR 81.4 million in 2023. End of Media Release Issuer: Alzchem Group AG Key word(s): Sports
12.11.2024 CET/CEST Dissemination of a Press Release, transmitted by EQS News - a service of EQS Group AG. |
Language: | English |
Company: | Alzchem Group AG |
Dr.-Albert-Frank-Str. 32 | |
83308 Trostberg | |
Germany | |
Phone: | +498621862888 |
Fax: | +49862186502888 |
E-mail: | ir@alzchem.com |
Internet: | www.alzchem.com |
ISIN: | DE000A2YNT30 |
WKN: | A2YNT3 |
Indices: | SDAX |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Stuttgart |
EQS News ID: | 2027527 |
End of News | EQS Media |
|
2027527 12.11.2024 CET/CEST
Nachrichten zu AlzChem Group AG Inhaber-Akt Nach Kapitalherabsetzung
15:58 |
Börse Frankfurt: So bewegt sich der SDAX am Freitagnachmittag (finanzen.ch) | |
23.12.24 |
EQS-News: Alzchem Group AG: Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052 - 3rd Interim Report (EQS Group) | |
23.12.24 |
EQS-News: Alzchem Group AG: Bekanntmachung nach Art. 5 der Verordnung (EU) 596/2014 und Art. 2 Abs. 1 der Delegierten Verordnung (EU) 2016/1052 - 3. Zwischenmeldung (EQS Group) | |
19.12.24 |
Anleger in Frankfurt halten sich zurück: SDAX verbucht letztendlich Verluste (finanzen.ch) | |
19.12.24 |
Börse Frankfurt in Rot: SDAX zeigt sich am Donnerstagnachmittag schwächer (finanzen.ch) | |
19.12.24 |
SDAX-Handel aktuell: So performt der SDAX am Donnerstagmittag (finanzen.ch) | |
19.12.24 |
Anleger in Frankfurt halten sich zurück: SDAX gibt zum Start nach (finanzen.ch) | |
17.12.24 |
Schwacher Handel: SDAX fällt zum Start (finanzen.ch) |
Analysen zu AlzChem Group AG Inhaber-Akt Nach Kapitalherabsetzung
11.12.24 | AlzChem Group Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
11.11.24 | AlzChem Group Add | Baader Bank |
Robert Halver: Jahresrückblick 2024 | BX TV
Im ersten Teil des grossen Jahresinterviews wirft David Kunz, COO der BX Swiss, wir mit Robert Halver, Leiter der Kapitalmarktanalyse bei der Baader Bank AG einen Rückblick auf das Jahr 2024.
Wie auch im Jahr 2023 beschäftigt der Krieg in der Ukraine weiterhin die Welt, ebenfalls spitzt sich der Gaza Konflikt zu. Robert Halver erklärt, wie diese Konflikte die Finanzmärkte bewegt haben und welche Auswirkungen die Zinssenkungen der Notenbanken auf die Märkte genommen hat.
👉🏽 Jetzt auch auf BXplus anmelden und von exklusiven Inhalten rund um Investment & Trading profitieren!
Inside Trading & Investment
Mini-Futures auf SMI
Inside Fonds
Meistgelesene Nachrichten
Börse aktuell - Live Ticker
Dow tiefer -- SMI und DAX gehen fester ins Wochenende -- Asiens Börsen schliessen uneinigDie US-Börsen zeigen sich vor dem Wochenende deutlich schwächer. Der heimische und deutsche Aktienmarkt notierten am Freitag im Plus. Die asiatischen Aktienmärkte präsentierten sich am Freitag uneins.
finanzen.net News
Datum | Titel |
---|---|
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
|
{{ARTIKEL.NEWS.BODY.TITEL}} |